Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision changed from v3.3.1 to v3.3.2; no other content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T10:55:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The history shows additions of Revision: v3.3.1 and Results Submission Events set to 3, and removals of Revision: v3.2.0 and Results Submission Events set to 2.
    Difference
    0.2%
    Check dated 2025-11-24T10:55:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The government funding notice banner was removed from the page.
    Difference
    0.6%
    Check dated 2025-11-17T06:03:06.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The new screenshot shows a refreshed page layout and header; the underlying study record history content remains unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T00:41:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    11%
    Check dated 2025-10-05T06:49:48.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:53:08.000Z thumbnail image

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.